甲状腺髓样癌：所综述的第三常见的甲状腺癌。
Medullary thyroid carcinoma: The third most common thyroid cancer reviewed.
作者信息
Stamatakos Michael, Paraskeva Panoraia, Stefanaki Charikleia, Katsaronis Paraskevas, Lazaris Andreas, Safioleas Konstantinos, Kontzoglou Konstantinos
机构信息
Fourth Department of Surgery, School of Medicine, Athens University, Attikon Hospital, Athens, Greece.
出版信息
Oncol Lett. 2011 Jan;2(1):49-53. doi: 10.3892/ol.2010.223. Epub 2010 Nov 23.
Abstract
Medullary thyroid cancer is a type of thyroid cancer of neuroendocrine origin. It occurs in hereditary and sporadic forms, and its aggressive behavior is associated with the clinical presentation and type of RET mutation. Total thyroidectomy remains the ideal choice of treatment. Early diagnosis and treatment are the fundamental for a 100% cure rate. In this study, we present our experience of 3 cases, along with a complete review of the literature derived from a Pubmed Database search.
摘要
髓样甲状腺癌是一种神经内分泌起源的甲状腺癌。它以遗传性和散发性形式出现，其侵袭性行为与RET突变的临床表现和类型相关。全甲状腺切除术仍然是理想的治疗选择。早期诊断和治疗是实现100%治愈率的根本。在本研究中，我们介绍了3例病例的经验，并对通过PubMed数据库检索获得的文献进行了全面综述。
相似文献
1
Medullary thyroid carcinoma: The third most common thyroid cancer reviewed.
Oncol Lett. 2011 Jan;2(1):49-53. doi: 10.3892/ol.2010.223. Epub 2010 Nov 23.
2
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Ann Endocrinol (Paris). 2019 Jun;80(3):187-190. doi: 10.1016/j.ando.2019.04.014. Epub 2019 Apr 11.
3
Surgical approach to the management of medullary thyroid cancer: when is lymph node dissection needed?
Oncology. 2013;84(6):350-5. doi: 10.1159/000351148. Epub 2013 May 14.
4
New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
J Laryngol Otol. 2009 Jul;123(7):796-800. doi: 10.1017/S0022215108003472. Epub 2008 Sep 4.
5
RET proto oncogene mutation detection and medullary thyroid carcinoma prevention.
Asian Pac J Cancer Prev. 2015;16(6):2107-17. doi: 10.7314/apjcp.2015.16.6.2107.
6
Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age.
Curr Pediatr Rev. 2016;12(4):280-285. doi: 10.2174/1573396313666161111120936.
7
Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.
Crit Rev Clin Lab Sci. 2016 Aug;53(4):217-27. doi: 10.3109/10408363.2015.1129529. Epub 2016 Jan 27.
8
Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
Laryngoscope. 2006 Sep;116(9):1704-7. doi: 10.1097/01.mlg.0000233509.83679.ee.
9
Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
BMC Endocr Disord. 2019 Oct 16;19(1):103. doi: 10.1186/s12902-019-0435-7.
10
Medullary thyroid carcinoma--update and present management controversies.
Ann R Coll Surg Engl. 2006 Sep;88(5):433-8. doi: 10.1308/003588406X117043.
引用本文的文献
1
The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs.
Int J Mol Sci. 2025 Apr 12;26(8):3663. doi: 10.3390/ijms26083663.
2
The Efficacy and Safety of Anlotinib in the Treatment of Thyroid Cancer: A Systematic Review.
J Clin Med. 2025 Jan 8;14(2):338. doi: 10.3390/jcm14020338.
3
A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer.
BMC Cancer. 2024 Dec 23;24(1):1569. doi: 10.1186/s12885-024-13345-9.
4
Limited Thyroidectomy Achieves Equivalent Survival to Total Thyroidectomy for Early Localized Medullary Thyroid Cancer.
Cancers (Basel). 2024 Dec 4;16(23):4062. doi: 10.3390/cancers16234062.
5
Non-secretory medullary thyroid carcinoma with laryngotracheal invasion: a case report and review of the literature.
AME Case Rep. 2024 Aug 2;8:87. doi: 10.21037/acr-24-45. eCollection 2024.
6
LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
Curr Cancer Drug Targets. 2024;24(5):519-533. doi: 10.2174/0115680096258716231026063704.
7
The Evolving Treatment Landscape of Medullary Thyroid Cancer.
Curr Treat Options Oncol. 2023 Dec;24(12):1815-1832. doi: 10.1007/s11864-023-01145-5. Epub 2023 Nov 18.
8
Development of the First F-Labeled Radiohybrid-Based Minigastrin Derivative with High Target Affinity and Tumor Accumulation by Substitution of the Chelating Moiety.
Pharmaceutics. 2023 Mar 3;15(3):826. doi: 10.3390/pharmaceutics15030826.
9
Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo.
Pharmaceuticals (Basel). 2022 Nov 25;15(12):1467. doi: 10.3390/ph15121467.
10
Synchronous Hürthle cell and medullary thyroid carcinomas.
BMJ Case Rep. 2022 May 31;15(5):e248879. doi: 10.1136/bcr-2022-248879.
本文引用的文献
1
Sonography and fine-needle aspiration biopsy in the diagnosis of benign versus malignant nodules in patients with autoimmune thyroiditis.
J Clin Ultrasound. 2009 Nov-Dec;37(9):487-92. doi: 10.1002/jcu.20633.
2
Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.
Clinics (Sao Paulo). 2009;64(7):699-706. doi: 10.1590/S1807-59322009000700015.
3
Surgical approaches in thyroid cancer and lymph-node metastases.
Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):971-87. doi: 10.1016/j.beem.2008.09.018.
4
Current management of medullary thyroid cancer.
Oncologist. 2008 May;13(5):539-47. doi: 10.1634/theoncologist.2007-0239.
5
New therapeutic approaches to treat medullary thyroid carcinoma.
Nat Clin Pract Endocrinol Metab. 2008 Jan;4(1):22-32. doi: 10.1038/ncpendmet0717.
6
Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.
Histol Histopathol. 2008 Jan;23(1):109-16. doi: 10.14670/HH-23.109.
7
Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia.
Carcinogenesis. 2008 Mar;29(3):620-8. doi: 10.1093/carcin/bgm207. Epub 2007 Sep 24.
8
Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma.
Biomed Pharmacother. 2008 Mar;62(3):139-46. doi: 10.1016/j.biopha.2007.07.011. Epub 2007 Aug 20.
9
Surgical approach to medullary thyroid cancer.
Arq Bras Endocrinol Metabol. 2007 Jul;51(5):818-24. doi: 10.1590/s0004-27302007000500020.
10
Neck management in medullary thyroid carcinoma.
Eur J Surg Oncol. 2008 Jan;34(1):71-6. doi: 10.1016/j.ejso.2007.03.020. Epub 2007 Jun 6.
Zotero 插件